Abstract:Background: Multiple sclerosis (MS) is an immune-mediated central nervous system disease characterized by inflammation, demyelination and axonal degeneration. The pathology of MS suggests an autoimmune cause involving cellular and humoral components of the immune system. Active MS lesions are characterized by T-cell and macrophage infiltration and the presence of immune mediators, including adhesion molecules, chemokines, and cytokines. Cytokines are proven mediators of immunological process in MS. The aim of this study was to delineate the serum cytokine profile in patients with MS and the controls and to determine in different clinical forms of MS. Methods: This study involved 62 consecutive MS patients--28 patients with progressive MS and 34 patients with relapsing-remitting MS (RRMS). The control group consisted of 18, age and sex matched, non-immunological, neurological patients. The patients were evaluated using the Expanded Disability Status Scale (EDSS) and magnetic resonance imaging (MRI) with gadolinium. Serum samples for cytokine measurements were collected on admission. Plasma levels of proinflammatory T-helper (TH)1 (interferon (IFN)-γ) cytokines, peripheral monokines (IL-1beta, IL-6, TNF-alpha) and anti-inflammatory or down-regulatory TH2 cytokines (IL-4, IL-10) were determined by an enzyme-linked immunosorbent assay (ELISA) method. Results: All patients with MS had significantly higher cytokine (IFN-γ, IL-1β, IL-6, TNF-α, IL-4, IL-10) concentrations compared with controls (p < 0.001). Increased IL1beta, IFN-γ (p=0.032 and 0.041, respectively) and decreased IL-4, IL-10 (p=0.038 and 0.02, respectively) levels were found in progressive MS compared with RRMS. Patients with progressive MS with disease progression presented higher IL-1beta, TNF-alpha, IFN-γ and IL-10 levels than those without disease progression (p < 0.05). There was a significant inverse correlation between IL-10 levels and EDSS score in patients with progressive MS (R = 0.43, p < 0.05). Conclusion: Profiling cytokines in multiple sclerosis may help to identify mechanisms involved in the pathogenesis of the disease, and, potentially, lead to new therapies directed at cytokines or their receptors. The level of IL-10 can serve as an additional diagnostic criterion for assessing the disability in patients with progressive MS.

Increased Serum Tumor Necrosis Factor Alpha Concentrations in Major Depression and Multiple Sclerosis.

Increased Serum IL-6 and IL-1 Receptor Antagonist Concentrations in Major Depression and Treatment Resistant Depression.

A-100 Selected pro-and anti-inflammatory cytokine serum concentrations in different clinical forms of multiple sclerosis

Immunological Differences Between Patients with Major Depression and Somatization Syndrome

Increased Plasma Concentrations of Interleukin-6, Soluble Interleukin-6, Soluble Interleukin-2 and Transferrin Receptor in Major Depression.

Increased Serum Interleukin-1-receptor-antagonist Concentrations in Major Depression

Changes in the Serum Levels of Inflammatory Cytokines in Antidepressant Drug-Naïve Patients with Major Depression

Effects of Antidepressants on the Production of Cytokines.

Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions

Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation

Fluoxetine Treatment for Major Depression Decreases the Plasma Levels of Cytokines

Serum Interleukin Levels and Insulin Resistance in Major Depressive Disorder

Tumor Necrosis Factor- Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment

Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment

Activation of the Inflammatory Response System: A New Look at the Etiopathogenesis of Major Depression.

Research of cytokines change in multiple sclerosis patients with depression

Inflammatory Markers in Depressed Post-Myocardial Infarction Patients.

Interferon-α-induced depressive symptoms are related to changes in the cytokine network but not to cortisol

Significantly Increased Expression of T-cell Activation Markers (Interleukin-2 and HLA-DR) in Depression: Further Evidence for an Inflamatory Process During That Illness

Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression.

Association between inflammatory cytokines and symptoms of major depressive disorder in adults